LINDA ARMSTRONG: Open Payments
NPI 1720527211 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 14 payments from 9 companies in 2025. Trend: 2023 $81 · 2024 $348 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| GENZYME CORPORATION | 2 | $61 |
| Kite Pharma, Inc. | 2 | $56 |
| Blueprint Medicines Corporation | 1 | $40 |
| SOBI, INC | 1 | $36 |
| Rigel Pharmaceuticals, Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| SERVIER PHARMACEUTICALS LLC | 1 | $18 |
Products named: AYVAKIT, SCEMBLIX, Yescarta, Vonjo, TAVALISSE, KEYTRUDA, BOSULIF, Tibsovo.
Industry payments across NY — which companies pay providers there.
